Regeneus Ltd. (AU:CMB) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Cambium Bio Limited is set to hold its Annual General Meeting on November 26, 2024, where shareholders will review the company’s financial statements and vote on key resolutions, including the adoption of the Remuneration Report and the re-election of Dr. Yu-Hung Sebastian Tseng as Director. This meeting offers investors an opportunity to gain insights into the company’s performance and strategic direction.
For further insights into AU:CMB stock, check out TipRanks’ Stock Analysis page.